ArticleNeurology. Genetics2026
Pediatric Cohort of Charcot-Marie-Tooth Disease: Clinical Features and Genetic Distribution.
Article in Neurology. Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of hereditary peripheral neuropathies. While pediatric-onset CMT exhibits unique clinical and genetic characteristics, data on this subset remain sparse. This study investigates the clinical and genetic features of a pediatric CMT cohort in a single center in ON, Canada. Methods: A retrospective cross-sectional study reviewed data from patients diagnosed with CMT disease at The Hospital for Sick Children between 2013 and 2022. Genetic testing targeted up to 87 genes linked to CMT, with patient demographics, clinical features, electrodiagnostic findings, and orthopaedic complications analyzed using descriptive and inferential statistics. Results: Sixty-one patients from 14 genetically confirmed subtypes were included (29 female patients, 32 male patients). The median age at diagnosis was 7.7 years (range 1-17). Overall, foot deformities were present in 84% of patients, Achilles contractures in 42%, hammertoes in 28%, hip dislocation in 10%, and scoliosis in 23%. Discussion: This study provides a description of pediatric CMT disease in a Canadian cohort. We show that while genetic distributions mirror international data, family-based genetic screening can identify children even before clinical onset, and that orthopaedic complications are already common in early childhood. These findings reinforce the importance of early genetic confirmation, orthopaedic surveillance, and expanded sequencing strategies to improve care and refine genotype-phenotype correlations in pediatric CMT disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.